37481 |
Oncology |
Ramosetron versus Palonosetron in Combination with Aprepitant and Dexa... |
CANCER RES TREAT 2020 10.4143/crt.2019.713 |
안진석 |
2020 |
37480 |
Oncology |
Prognostication of a 13-immune-related-gene signature in patients with... |
BREAST CANCER RES TR 2020 10.1007/s10549-020-05874-1 |
안진석 |
2020 |
37479 |
Pharmacology & Pharmacy |
Phase I clinical trial of KML001 monotherapy in patients with advanced... |
EXPERT OPIN INV DRUG 2020 10.1080/13543784.2020.1804855 |
안진석 |
2020 |
37478 |
Oncology; Respiratory System |
Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NS... |
J THORAC ONCOL 2020 10.1016/j.jtho.2020.06.018 |
안진석 |
2020 |
37477 |
Multidisciplinary Sciences |
Metabolic radiogenomics in lung cancer associations between FDG PET im... |
SCI REP-UK 2020 10.1038/s41598-020-70168-x |
안진석 |
2020 |
37476 |
Immunology |
Immunological Characteristics of Hyperprogressive Disease in Patients ... |
IMMUNE NETW 2020 10.4110/in.2020.20.e48 |
안진석 |
2020 |
37475 |
Oncology |
HLA-corrected tumor mutation burden and homologous recombination de fi... |
ANN ONCOL 2020 10.1016/j.annonc.2020.04.004 |
안진석 |
2020 |
37474 |
Pharmacology & Pharmacy |
Evaluating entrectinib as a treatment option for non-small cell lung c... |
EXPERT OPIN PHARMACO 2020 10.1080/14656566.2020.1798932 |
안진석 |
2020 |
37473 |
Oncology |
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell L... |
CANCER RES TREAT 2020 10.4143/crt.2020.278 |
안진석 |
2020 |
37472 |
Oncology; Cell Biology |
Clinical Characteristics and Exploratory Genomic Analyses of Germline ... |
MOL CANCER RES 2020 10.1158/1541-7786.MCR-19-1108 |
안진석 |
2020 |